“Trastuzumab in Combination with Traditional Chemotherapy is better than Chemotherapy Alone in HER2 Positive Breast Cancer Patients” (2018) TAJ: Journal of Teachers Association, 30(1), pp. 30–35. doi:10.3329/taj.v30i1.39120.